Court News
Delhi High Court Rejects Novo Nordisk Plea, Dr. Reddy’s Can Continue Manufacturing Semaglutide
Delhi High Court rejects Novo Nordisk’s plea, allowing Dr. Reddy’s to manufacture and export semaglutide. Indian sales remain barred until the patent expires in 2026.